Cavitation Technologies signs $35 million cash tender offer deal with BrightFlixx Finance, replacing EGS agreement
CVAT•BrightFlixx Finance agreed to launch all-cash tender offers for all outstanding shares of Cavitation Technologies and Alchemy Beverages, with proposed consideration totaling $42 million: $35 million for Cavitation and $7 million for Alchemy.
1. New tender offer agreements
The new agreements with BrightFlixx Finance replace prior tender offer arrangements with European Guarantee Services, which were terminated. Financing remains backed by Bright Wealth Banking, the institution involved in the earlier process.
